BHO Assessing the Preparedness of the Korean Healthcare System Infrastructure for an Alzheimer’s Treatment January 1, 2020
BHO Implications of Alzheimer’s Treatment for OrganizationAnd Payment of Medical Practices in the Eu-5 Countries January 1, 2020
BHO Assessing the Preparedness of the Australian Health Care System Infrastructure for an Alzheimer’s Disease-Modifying Therapy September 21, 2019
BHO The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey January 1, 2019
BHO The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia January 1, 2019
BHO Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer’s Treatment January 1, 2019
BHO Assessing the Preparedness of the Japanese Health Care System Infrastructure for an Alzheimer’s Treatment January 1, 2019
BHO Assessing the Preparedness of the Canadian Health Care System Infrastructure for an Alzheimer’s Treatment January 1, 2019
BHO Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia January 1, 2018
